TVTX
TVTX
NASDAQ · Biotechnology

Travere Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$55.15
+1.01 (+1.87%)
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 19 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target -32.6% upside
Low Target $26.93
Average Target $37.15
High Target $48.45
Current Price $55.15
Current
$55.15
Target
$37.15
$26.93 $37.15 avg $48.45
Scenario Analysis
Bear Case
$26.93
-51.2%
Low target
Base Case
$37.15
-32.6%
Avg target
Bull Case
$48.45
+-12.1%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$55.99
-1.5% from high
52-Week Low
$13.88
+297.3% from low
50-Day SMA
$32.84
+67.9% vs SMA
200-Day SMA
$24.79
+122.5% vs SMA
RSI (14)
40.3
Neutral
Target vs 52W High
$37.15
-33.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +12.0%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -44.6%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.1%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.5%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -31.2%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -37.5%